当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3576262
自主品牌
已选条件
-
T26253TecastemizoleR43512；R-43512；Norastemizole；R 43512；T 1348
Tecastemizole, a major metabolite of astemizole, is a selective H1 receptor antagonist. It may possess anti-inflammatory effects.
价 格：￥电议型 号：T26253产 地：中国大陆
-
T2619CH5132799
CH5132799 has been used in trials studying the treatment of Solid Tumors.
价 格：￥电议型 号：T2619产 地：中国大陆
-
T2586Cabozantinib卡博替尼；XL184；BMS-907351
Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2, c-Met, Kit, Axl, and Flt3 (IC50s: 0.035, 1.3, 4.6, 7 and 11.3 nM).
价 格：￥电议型 号：T2586产 地：中国大陆
-
T2526CiclesonideZetonna；Omnaris；RPR251526；Alvesco；环索奈德
Ciclesonide(RPR251526) is a glucocorticoid used for the treatment of obstructive airway diseases.
价 格：￥电议型 号：T2526产 地：中国大陆
-
T25196BZAD01BZAD 01；BZAD-01
BZAD01 is a selective NMDA NR1A/2B receptor antagonist.
价 格：￥电议型 号：T25196产 地：中国大陆
-
T2517SCH900776MK 8776；MK-8776
CHK1 Inhibitor MK-8776 is an agent targeting cell cycle checkpoint kinase 1 (Chk1) with potential radiosensitization and chemosensitization activities.
价 格：￥电议型 号：T2517产 地：中国大陆
-
T2516AmuvatinibHPK 56；MP470
Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
价 格：￥电议型 号：T2516产 地：中国大陆
-
T25150BI-69A11BI 69A11；BI69A11；(E)-3-(1H-Benzo[d]imidazol-2-yl)-1-(6-chloro-2-hydroxy-4-phenylquinolin-3-y
BI-69A11 is a dual AKT and NFkB pathway inhibitor. It enhances the susceptibility of colon cancer cells to mda-7/IL-24-induced growth inhibition by targeting Akt.
价 格：￥电议型 号：T25150产 地：中国大陆
-
-
T2514LinifanibRG3635；ABT-869；AL-39324
Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR (IC50: 4 nM), CSF-1R (IC50: 3 nM), Flt-1/3 (IC50: 3/4 nM) and PDGFRβ (IC50: 66 nM). Linifanib may exhibit potent antiproliferative and apoptotic effects on tumor cells wh
价 格：￥电议型 号：T2514产 地：中国大陆
-
T2513VX-702VX702；VX 702
VX-702 is a highly specific p38α MAPK inhibitor, 14-fold higher selectivity for the p38α than p38β. VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA).
价 格：￥电议型 号：T2513产 地：中国大陆
-
T2512MocetinostatMGCD0103；MG0103
Mocetinostat is an orally available HDAC inhibitor with most potency for HDAC1 (IC50: 0.15 μM), 2- to 10- fold selectivity against HDAC2/3/11.
价 格：￥电议型 号：T2512产 地：中国大陆
-
T2511Plinabulin普那布林；NPI-2358
Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing tumor cells ( IC50: 9.8-18 nM). Plinabulin selectively targets and binds to the colchicine-binding site of tubulin, thereby interrupting equilibrium of microtubule d
价 格：￥电议型 号：T2511产 地：中国大陆
-
T2510GalunisertibLY2157299
Galunisertib is an orally available inhibitor of TGFβRI kinase (IC50: 56 nM) with potential antineoplastic activity.
价 格：￥电议型 号：T2510产 地：中国大陆
-
T2493PD 151746
PD 151746 is a selective, cell-permeable calpain inhibitor (Ki: 0.26/5.33 μM, μ-Calpain/m-calpain).
价 格：￥电议型 号：T2493产 地：中国大陆
-
T2477UNBS5162UNBS 5162；UNBS-5162
UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
价 格：￥电议型 号：T2477产 地：中国大陆
-
T2462SB-505124SB 505124；SB505124
SB505124 is a selective inhibitor of TGFβR for ALK4, ALK5.
价 格：￥电议型 号：T2462产 地：中国大陆
-
T2456Tivozanib替沃扎尼；KRN951；AV-951
Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor receptors (VEGFRs) 1, 2 and 3 with potential antiangiogenic and antineoplastic activities.
价 格：￥电议型 号：T2456产 地：中国大陆
-
T2451GlyH-101GlyH 101；GlyH101
GlyH-101 is a cell-permeable glycinyl hydrazone compound that blocks CFTR with Ki of 1.4 uM.
价 格：￥电议型 号：T2451产 地：中国大陆
-
T2446KI8751
KI8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM.
价 格：￥电议型 号：T2446产 地：中国大陆
